August 20, 2020
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
This Notice informs potential applicants that the National Institute on Alcohol Abuse and Alcoholism (NIAAA) is participating, effective immediately, in PAR-19-064, "Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional)".
The following changes are made to PAR-19-064 (shown in italics) to reflect NIAAA's participation in this FOA.
Part 1. Overview Information
Components of Participating Organizations
National Institute on Drug Abuse (NIDA)
National Cancer Institute (NCI)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Catalog of Federal Domestic Assistance (CFDA) Number(s)
93.279, 93.399, 93.273
Part 2. Section I. Funding Opportunity Description
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
NIAAA participation in this Funding Opportunity Announcement (FOA) will support pilot, feasibility, exploratory, or developmental research in public health priority areas in substance use epidemiology, prevention, and health services, including but not necessarily limited to:
To be supported under this PAR, applicants must demonstrate that the proposed study could not be conducted under standard review and award timelines.
Part 2. Section VII. Agency Contacts
Scientific/Research Contact(s)
Gregory Bloss, M.A., M.P.P.
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Telephone: 301-443-3865
Email: [email protected]
Financial/Grants Management Contact(s)
Judy Fox
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Telephone: 301-443-4704
Email: [email protected]
All other aspects of the FOA remain the same.
Gregory Bloss, M.A., M.P.P.
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Telephone: 301-443-3865
Email: [email protected]